Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Alicja Urbaniak

TitleInstructor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentBiochemistry & Molecular Biology, College of Medicine
DivisionBiochem & Molecular Histone Epigenet
Address325 S. Elm St.
Mail Slot # 516
Little Rock AR 72205
Phone501-686-5755
ORCID ORCID Icon0000-0002-0807-1263 Additional info
vCardDownload vCard

    Collapse Overview 

    Collapse Affiliation 
    Collapse member of
    American Society for Pharmacology and Experimental Therapeutics (ASPET)
    American Chemical Society
    Polish Chemical Society

    Collapse Biography 
    Collapse education and training
    Adam Mickiewicz University, Poznan, PolandBSc06/2010Chemistry
    Adam Mickiewicz University, Poznan, PolandMSc06/2012Chemistry
    Adam Mickiewicz University, Poznan, PolandPhD10/2017Chemistry
    Poznan University of Physical Education, Poznan, PolandPhD12/2021Health Sciences

    Collapse Outreach 

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Urbaniak A, Thummel KE, Alade AN, Rettie AE, Prasad B, De Nicol? A, Martin JH, Sheppard DN, Jarvis MF. Experimental pharmacology in precision medicine. Pharmacol Res Perspect. 2023 Dec; 11(6):e01147. PMID: 37885364.
      View in: PubMed
    2. Urbaniak A, Bathula C, Chauhan J, Rai P, Thammathong J, Clark C, Heflin B, De Loose A, Avaritt N, Rodriguez A, Tackett AJ, Sen S, Banerjee S. Synthesis and Anti-Melanoma Activity of Acryloyl Pyridinone Analogues. Chem Biodivers. 2023 Dec; 20(12):e202301550. PMID: 37994208.
      View in: PubMed
    3. Moreira ARS, Lim J, Urbaniak A, Banik J, Bronson K, Lagasse A, Hardy L, Haney A, Allensworth M, Miles TK, Gies A, Byrum SD, Wilczynska A, Boehm U, Kharas M, Lengner C, MacNicol MC, Childs GV, MacNicol AM, Odle AK. Musashi Exerts Control of Gonadotrope Target mRNA Translation During the Mouse Estrous Cycle. Endocrinology. 2023 08 01; 164(9). PMID: 37477898.
      View in: PubMed
    4. Lowenthal R, Taylor M, Gidden JA, Heflin B, Lay JO, Avaritt N, Tackett AJ, Urbaniak A. The mycelium of the Trametes versicolor synn. Coriolus versicolor (Turkey tail mushroom) exhibit anti-melanoma activity in vitro. Biomed Pharmacother. 2023 May; 161:114424. PMID: 36827712.
      View in: PubMed
    5. Urbaniak A, Reed MR, Heflin B, Gaydos J, Pi?a-Oviedo S, Jedrzejczyk M, Klejborowska G, Stepczynska N, Chambers TC, Tackett AJ, Rodriguez A, Huczynski A, Eoff RL, MacNicol AM. Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer. Biomed Pharmacother. 2022 Sep; 153:113440. PMID: 36076555.
      View in: PubMed
    6. Delgado M, Rainwater RR, Heflin B, Urbaniak A, Butler K, Davidson M, Protacio RM, Baldini G, Edwards A, Reed MR, Raney KD, Chambers TC. Primary acute lymphoblastic leukemia cells are susceptible to microtubule depolymerization in G1 and M phases through distinct cell death pathways. J Biol Chem. 2022 06; 298(6):101939. PMID: 35436470.
      View in: PubMed
    7. Shoeib AM, Yarbrough AL, Ford BM, Franks LN, Urbaniak A, Hensley LL, Benson LN, Mu S, Radominska-Pandya A, Prather PL. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development. Life Sci. 2021 Nov 15; 285:119993. PMID: 34592231.
      View in: PubMed
    8. Delgado M, Washam CL, Urbaniak A, Heflin B, Storey AJ, Lan RS, Mackintosh SG, Tackett AJ, Byrum SD, Chambers TC. Phosphoproteomics Provides Novel Insights into the Response of Primary Acute Lymphoblastic Leukemia Cells to Microtubule Depolymerization in G1 Phase of the Cell Cycle. ACS Omega. 2021 Sep 28; 6(38):24949-24959. PMID: 34604676.
      View in: PubMed
    9. Urbaniak A, Reed MR, Fil D, Moorjani A, Heflin S, Antoszczak M, Sulik M, Huczynski A, Kupsik M, Eoff RL, MacNicol MC, Chambers TC, MacNicol AM. Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models. Biomed Pharmacother. 2021 Sep; 141:111815. PMID: 34130123.
      View in: PubMed
    10. Klejborowska G, Urbaniak A, Maj E, Wietrzyk J, Moshari M, Preto J, Tuszynski JA, Chambers TC, Huczynski A. Synthesis, anticancer activity and molecular docking studies of N-deacetylthiocolchicine and 4-iodo-N-deacetylthiocolchicine derivatives. Bioorg Med Chem. 2021 02 15; 32:116014. PMID: 33465696.
      View in: PubMed
    11. Urbaniak A, Pi?a-Oviedo S, Yuan Y, Huczynski A, Chambers TC. Limitations of an ex vivo breast cancer model for studying the mechanism of action of the anticancer drug paclitaxel. Eur J Pharmacol. 2021 Jan 15; 891:173780. PMID: 33271152.
      View in: PubMed
    12. Urbaniak A, Jousheghany F, Pi?a-Oviedo S, Yuan Y, Majcher-Uchanska U, Klejborowska G, Moorjani A, Monzavi-Karbassi B, Huczynski A, Chambers TC. Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells-in vitro and ex vivo study. J Biochem Mol Toxicol. 2020 Jun; 34(6):e22487. PMID: 32141170.
      View in: PubMed
    13. Klejborowska G, Urbaniak A, Maj E, Preto J, Moshari M, Wietrzyk J, Tuszynski JA, Chambers TC, Huczynski A. Synthesis, biological evaluation and molecular docking studies of new amides of 4-chlorothiocolchicine as anticancer agents. Bioorg Chem. 2020 04; 97:103664. PMID: 32106039.
      View in: PubMed
    14. Czerwonka D, Urbaniak A, Sobczak S, Pi?a-Oviedo S, Chambers TC, Antoszczak M, Huczynski A. Synthesis and Anticancer Activity of Tertiary Amides of Salinomycin and Their C20-oxo Analogues. ChemMedChem. 2020 01 17; 15(2):236-246. PMID: 31702860.
      View in: PubMed
    15. Klejborowska G, Urbaniak A, Preto J, Maj E, Moshari M, Wietrzyk J, Tuszynski JA, Chambers TC, Huczynski A. Synthesis, biological evaluation and molecular docking studies of new amides of 4-bromothiocolchicine as anticancer agents. Bioorg Med Chem. 2019 12 01; 27(23):115144. PMID: 31653441.
      View in: PubMed
    16. Urbaniak A, Skarpanska-Stejnborn A. Effect of pomegranate fruit supplementation on performance and various markers in athletes and active subjects: A systematic review. Int J Vitam Nutr Res. 2021 Sep; 91(5-6):547-561. PMID: 31512981.
      View in: PubMed
    17. Urbaniak A, Jousheghany F, Yuan Y, Pi?a-Oviedo S, Huczynski A, Delgado M, Kieber-Emmons T, Monzavi-Karbassi B, Chambers TC. The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study. Oncol Lett. 2019 Nov; 18(5):5097-5106. PMID: 31612021.
      View in: PubMed
    18. Delgado M, Urbaniak A, Chambers TC. Contrasting effects of microtubule destabilizers versus stabilizers on induction of death in G1 phase of the cell cycle. Biochem Pharmacol. 2019 04; 162:213-223. PMID: 30578765.
      View in: PubMed
    19. Majcher U, Urbaniak A, Maj E, Moshari M, Delgado M, Wietrzyk J, Bartl F, Chambers TC, Tuszynski JA, Huczynski A. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes. Bioorg Chem. 2018 12; 81:553-566. PMID: 30248507.
      View in: PubMed
    20. Urbaniak A, Basta P, Ast K, Woloszyn A, Kurianska-Woloszyn J, Latour E, Skarpanska-Stejnborn A. The impact of supplementation with pomegranate fruit (Punica granatum L.) juice on selected antioxidant parameters and markers of iron metabolism in rowers. J Int Soc Sports Nutr. 2018 Jul 24; 15(1):35. PMID: 30041701.
      View in: PubMed
    21. Antoszczak M, Urbaniak A, Delgado M, Maj E, Borgstr?m B, Wietrzyk J, Huczynski A, Yuan Y, Chambers TC, Strand D. Biological activity of doubly modified salinomycin analogs - Evaluation in?vitro and ex?vivo. Eur J Med Chem. 2018 Aug 05; 156:510-523. PMID: 30025346.
      View in: PubMed
    22. Urbaniak A, Delgado M, Antoszczak M, Huczynski A, Chambers TC. Salinomycin derivatives exhibit activity against primary acute lymphoblastic leukemia (ALL) cells in vitro. Biomed Pharmacother. 2018 Mar; 99:384-390. PMID: 29367107.
      View in: PubMed
    23. Urbaniak A, Kujawski J, Czaja K, Szelag M. Antioxidant properties of several caffeic acid derivatives: A theoretical study. Comptes Rendus Chimie. 2017; 20(11-12):1072-1082.
      View Publication
    24. Urbaniak A, Delgado M, Kacprzak K, Chambers TC. Activity of resveratrol triesters against primary acute lymphoblastic leukemia cells. Bioorg Med Chem Lett. 2017 06 15; 27(12):2766-2770. PMID: 28499732.
      View in: PubMed
    25. Urbaniak A, Warzajtis B, Rychlewska U, Kacprzak K. Microwave-Assisted Synthesis of Aromatic and Aliphatic Triesters of Resveratrol. Synthesis (Germany). 2016; 07(48):1002-1010.
      View Publication
    26. Szelag M, Urbaniak A, Bluyssen HAR . A theoretical antioxidant pharmacophore for natural hydroxycinnamic acids. Open Chemistry. 2014; 13(1):17-31.
      View Publication
    27. Urbaniak A, Szelag M, Molski M. Theoretical investigation of stereochemistry and solvent influence on antioxidant activity of ferulic acid. Computational and Theoretical Chemistry. 2013; 1012:33-40.
      View Publication
    28. Urbaniak A, Molski M, Szelag M. Quantum-chemical Calculations of the Antioxidant Properties of trans-p-coumaric Acid and trans-sinapinic Acid. COMPUTATIONAL METHODS IN SCIENCE AND TECHNOLOGY. 2012; 2(18).
      View Publication
    Urbaniak's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (109) concept(s)
    _
    Co-Authors Expand Description
    See all (19) people
    _
    Similar People Expand Description
    See all (33) people
    _
    Same Department Expand Description
    Search Department